πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6713444

Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6706754

Reversed amidines and methods of using for treating, preventing, or inhibiting leishmanias

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6686333

Inhibition of HIV replication using soluble Tat peptide analogs

The United States of America as represented by the Department of Health and Human Resources Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6680374

Invaplex from gram negative bacteria, method of purification and methods of use

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6673559

Met proto-oncogene and a method for predicting breast cancer progression

The United States of America as Represented by the Government of the Department of Health and Human Services Β· Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6641815

Sequestrin

The United States of America as represented by the Secretary of the Army Β· Granted Tue Nov 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6638514

Multivalent dengue virus vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6632640

Vaccine against Staphylococcus intoxication

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6630144

Monoclonal antibodies to Ebola glycoprotein

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6620412

Prophylactic and therapeutic monoclonal antibodies

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6613556

Adaptation of virus to vertebrate cells

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6613883

Screening assays for compounds that cause apoptosis and related compounds

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6613740

Activity dependent neurotrophic factor III (ADNF III)

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6605619

Nitroxides as protectors against oxidatives stress

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 12 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6599449

X-ray crystallography reagent

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration Β· Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6573244

Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus ne

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 03 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6562376

DNA vaccines against poxviruses

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6559167

Prodrugs of proton pump inhibitors

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6558698

Microencapsulated bioactive agents and method of making

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration Β· Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6552006

Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6548068

Enhanced immune response to an antigen by a composition of a recombinant virus expressing

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6541230

Detoxification with sponges or foams containing plurality of enzymes and encapsulated indi

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6537557

Attenuated dengue-4 virus vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6528097

Sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired